X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (675) 675
Publication (29) 29
Book Review (8) 8
Book / eBook (4) 4
Book Chapter (3) 3
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (353) 353
orthopedics (295) 295
female (241) 241
index medicus (232) 232
male (222) 222
subtrochanteric fractures (215) 215
femur (207) 207
aged (200) 200
middle aged (186) 186
surgery (186) 186
subtrochanteric fracture (183) 183
fractures (165) 165
hip fractures - surgery (160) 160
adult (139) 139
aged, 80 and over (132) 132
radiography (128) 128
treatment outcome (120) 120
bone nails (109) 109
retrospective studies (99) 99
femoral fractures - surgery (91) 91
osteoporosis (88) 88
medicine & public health (83) 83
fixation (80) 80
fracture fixation, internal - methods (76) 76
hip fractures - diagnostic imaging (76) 76
fracture fixation, intramedullary - instrumentation (73) 73
gamma-nail (73) 73
emergency medicine (72) 72
femoral fractures - diagnostic imaging (69) 69
fracture fixation, internal - instrumentation (69) 69
fracture fixation, intramedullary - methods (69) 69
bone plates (68) 68
bone screws (67) 67
sport sciences (64) 64
intramedullary nail (61) 61
subtrochanteric (61) 61
critical care medicine (60) 60
femoral fractures (58) 58
hip (54) 54
dynamic hip screw (51) 51
follow-up studies (51) 51
internal fixation in fractures (51) 51
complications (50) 50
fracture healing (50) 50
internal-fixation (49) 49
adolescent (48) 48
bisphosphonates (48) 48
diphosphonates - adverse effects (47) 47
intertrochanteric fractures (45) 45
femur fractures (42) 42
bone density conservation agents - adverse effects (41) 41
intramedullary nailing (41) 41
care and treatment (40) 40
trochanteric fractures (40) 40
bisphosphonate (39) 39
fracture (39) 39
plate (39) 39
reoperation (38) 38
risk factors (38) 38
dynamic condylar screw (37) 37
endocrinology & metabolism (37) 37
intramedullary (36) 36
subtrochanteric femur fracture (36) 36
management (34) 34
nonunion (34) 34
prospective studies (34) 34
femur - surgery (33) 33
health aspects (33) 33
suppressed bone turnover (33) 33
traumatic surgery (32) 32
biomechanical phenomena (31) 31
femoral fractures - chemically induced (31) 31
hip fracture (31) 31
surgical orthopedics (31) 31
bone (30) 30
complication (30) 30
failure (30) 30
hip fractures - physiopathology (30) 30
proximal femoral nail (30) 30
screw (30) 30
analysis (28) 28
femoral-shaft fractures (28) 28
fracture fixation (28) 28
hip joint (28) 28
time factors (28) 28
young adult (28) 28
alendronate (27) 27
intertrochanteric fracture (27) 27
risk (27) 27
femoral fractures - epidemiology (26) 26
femur - diagnostic imaging (26) 26
internal fixation (26) 26
proximal femur (26) 26
experience (25) 25
hip screw (25) 25
nail (25) 25
biomechanics (24) 24
femoral fractures - etiology (24) 24
femoral neck fractures - surgery (24) 24
medicine, general & internal (24) 24
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (544) 544
German (57) 57
Korean (57) 57
French (10) 10
Spanish (6) 6
Czech (2) 2
Turkish (2) 2
Persian (1) 1
Polish (1) 1
Russian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Osteoporosis International, ISSN 0937-941X, 11/2018, Volume 29, Issue 11, pp. 2427 - 2435
aSummaryThe incidence of atypical femoral fractures (AFFs) was 2.95% among 6644 hip and femoral fractures. Independent risk factors included the use of... 
Atypical femoral fracture | Fracture healing | Bisphosphonates | Risk factors | Incidence | LOCATION | HIP | HETEROGENEITY | WOMEN | THERAPY | ENDOCRINOLOGY & METABOLISM | SUBTROCHANTERIC FRACTURES | EXPERIENCE | BISPHOSPHONATE TREATMENT | ASSOCIATION | FEMUR FRACTURES | Femoral Fractures - etiology | Osteoporosis, Postmenopausal - epidemiology | Fractures, Spontaneous - epidemiology | Humans | Middle Aged | Osteoporotic Fractures - diagnostic imaging | Osteoporosis, Postmenopausal - complications | Osteoporotic Fractures - etiology | Arthritis, Rheumatoid - complications | Case-Control Studies | Fracture Healing - drug effects | Aged, 80 and over | Female | Osteoporotic Fractures - epidemiology | Osteoporotic Fractures - physiopathology | Republic of Korea - epidemiology | Diphosphonates - adverse effects | Arthritis, Rheumatoid - physiopathology | Bone Density Conservation Agents - adverse effects | Fractures, Spontaneous - diagnostic imaging | Fractures, Spontaneous - physiopathology | Risk Factors | Arthritis, Rheumatoid - epidemiology | Hip Fractures - etiology | Femoral Fractures - epidemiology | Fractures, Spontaneous - etiology | Hip Fractures - epidemiology | Hip Fractures - physiopathology | Bone Density Conservation Agents - pharmacology | Femoral Fractures - diagnostic imaging | Radiography | Hip Fractures - diagnostic imaging | Osteoporosis, Postmenopausal - physiopathology | Aged | Femoral Fractures - physiopathology | Diphosphonates - pharmacology | Complications and side effects | Dosage and administration | Fractures | Research | Drug therapy | Diphosphonates | Femur | Medical records | Bone healing | Patients | Hip | Osteoporosis | Rheumatoid arthritis | Health risk assessment | Osteopenia
Journal Article
Journal Article
Clinical Orthopaedics and Related Research, ISSN 0009-921X, 9/2014, Volume 472, Issue 9, pp. 2728 - 2734
Journal Article
Skeletal Radiology, ISSN 0364-2348, 1/2019, Volume 48, Issue 1, pp. 29 - 45
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 11/2010, Volume 25, Issue 11, pp. 2267 - 2294
Journal Article
1993, ISBN 9780632032631, xi, 292
Book
Annals of the New York Academy of Sciences, ISSN 0077-8923, 01/2015, Volume 1335, Issue 1, pp. 1 - 9
Journal Article
Clinical Orthopaedics and Related Research, ISSN 0009-921X, 8/2012, Volume 470, Issue 8, pp. 2295 - 2301
Bisphosphonate-associated femur fractures have been well described but the preoperative patient factors, treatment modalities, and complications of treatment... 
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Surgery | Orthopedics | Conservative Orthopedics | Medicine/Public Health, general | SURGERY | SUBTROCHANTERIC STRESS-FRACTURES | WOMEN | POSTMENOPAUSAL OSTEOPOROSIS | NONVERTEBRAL FRACTURES | FEMORAL INSUFFICIENCY FRACTURES | PREVENTION | TERM ALENDRONATE THERAPY | MICRODAMAGE ACCUMULATION | BONE | MEVALONATE PATHWAY | ORTHOPEDICS | Teriparatide - therapeutic use | Bone Density - physiology | Humans | Middle Aged | Osteoporotic Fractures - diagnostic imaging | Osteoporosis - drug therapy | Osteoporosis - metabolism | Diphosphonates - therapeutic use | Fracture Fixation, Internal | Female | Retrospective Studies | Drug Therapy, Combination | Diphosphonates - adverse effects | Femoral Fractures - chemically induced | Postoperative Complications | Bone Density Conservation Agents - adverse effects | Bone Density Conservation Agents - therapeutic use | Absorptiometry, Photon | Femoral Fractures - diagnostic imaging | Bone Density - drug effects | Fracture Healing | Osteoporotic Fractures - chemically induced | Osteoporotic Fractures - surgery | Osteoporosis - complications | Femoral Fractures - surgery | Aged | Osteoporosis | Medical colleges | Fractures | Phosphonates | Internal fixation in fractures | Statistics | Health aspects | Consulting services | Femur | Cortex | Adjuvants | Bisphosphonates | Risk factors | Clinical Research
Journal Article
Journal Article
Osteoporosis International, ISSN 0937-941X, 12/2012, Volume 23, Issue 12, pp. 2873 - 2884
In a cohort study of users of bisphosphonates, we evaluated the incidence of fragility fractures at all sites on the femur following for up to 8 years of... 
Medicine & Public Health | Low-energy femoral fractures | Orthopedics | Gynecology | Atypical femur fractures | Femoral shaft fractures | Rheumatology | Fragility fractures | Medication possession ratio | Subtrochanteric fractures | Oral bisphosphonates | Endocrinology | Low-energyfemoral fractures | REGRESSION-MODELS | PERSISTENCE | ENDOCRINOLOGY & METABOLISM | RISK | ADHERENCE | Femoral Fractures - etiology | United States - epidemiology | Humans | Middle Aged | Male | Osteoporosis - drug therapy | Alendronate - therapeutic use | Incidence | Hip Fractures - prevention & control | Diphosphonates - therapeutic use | Female | Etidronic Acid - therapeutic use | Osteoporotic Fractures - epidemiology | Risedronate Sodium | Etidronic Acid - analogs & derivatives | Etidronic Acid - administration & dosage | Drug Administration Schedule | Administration, Oral | Osteoporotic Fractures - prevention & control | Femoral Fractures - epidemiology | Diphosphonates - administration & dosage | Hip Fractures - epidemiology | Osteoporosis - complications | Femoral Fractures - prevention & control | Aged | Alendronate - administration & dosage | Cohort Studies | Databases | Fractures | Analysis | Phosphonates | Hip joint | Osteoporosis | Legs | Drug therapy | Alendronic acid | Femur | Risedronic acid | Risk assessment | Data processing | Models | Bisphosphonates | Hip | Long-term effects
Journal Article